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ABSTRACT  The mediator protein Claspin is critical for the activation of the checkpoint ki-
nase Chk1 during checkpoint responses to stalled replication forks. This function involves the 
Chk1-activating domain (CKAD) of Claspin, which undergoes phosphorylation on multiple 
conserved sites. These phosphorylations promote binding of Chk1 to Claspin and ensuing 
activation of Chk1 by ATR. However, despite the importance of this regulatory process, the 
kinase responsible for these phosphorylations has remained unknown. By using a multifac-
eted approach, we have found that casein kinase 1 gamma 1 (CK1γ1) carries out this func-
tion. CK1γ1 phosphorylates the CKAD of Claspin efficiently in vitro, and depletion of CK1γ1 
from human cells by small interfering RNA (siRNA) results in dramatically diminished phos-
phorylation of Claspin. Consequently, the siRNA-treated cells display impaired activation of 
Chk1 and resultant checkpoint defects. These results indicate that CK1γ1 is a novel compo-
nent of checkpoint responses that controls the interaction of a key checkpoint effector ki-
nase with its cognate mediator protein.
INTRODUCTION
In eukaryotic cells, duplication of the genome and cell division must 
be coordinated faithfully. Otherwise, genomic defects might be 
propagated to progeny cells. In vertebrates, the checkpoint kinase 
Chk1 plays a critical role in preventing the continuation of the cell 
cycle if the genome has undergone any perturbation (Cimprich and 
Cortez, 2008). Genomic disruptions trigger the prompt activation of 
Chk1, which in turn phosphorylates key cell cycle control enzymes 
such as Cdc25 and Wee1. These reactions dampen the activation of 
cyclin-dependent kinases (Cdks) until the cell can rectify lesions in 
the DNA. The activation of Chk1 involves phosphorylation of its C-
terminal regulatory domain on multiple sites by a master checkpoint 
regulatory kinase called ATM- and Rad3-related kinase (ATR). ATR 
exists in a tight complex with a partner called ATR-interacting pro-
tein (ATRIP; Cortez et al., 2001; Zou and Elledge, 2003). Upon oc-
currence of replication blockages in the nucleus, for example, the 
ATR–ATRIP complex undergoes activation in a manner that depends 
upon an intricate upstream regulatory pathway. In vertebrates, the 
culmination of this pathway results in the physical association of 
ATR–ATRIP with a specific activating protein known as topoi-
somerase IIb-binding protein 1 (TopBP1; Kumagai et al., 2006; 
Mordes et al., 2008).
Significantly, the activated ATR–ATRIP complex also requires the 
assistance of a mediator or adaptor protein to effectively phospho-
rylate Chk1. In vertebrates, this protein is known as Claspin (Kumagai 
and Dunphy, 2000; Chini and Chen, 2003; Lee et al., 2003; Lin et al., 
2004). ATR has a higher propensity to recognize the Claspin–Chk1 
complex than the isolated Chk1 protein (Kumagai et al., 2004; Lind-
sey-Boltz et al., 2009). Significantly, Claspin also interacts in a highly 
specific manner with replication forks, which suggests this protein 
helps the cell to monitor the progress of DNA replication (Lee et al., 
2005; Petermann et al., 2008; Scorah and McGowan, 2009). The 
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dramatically reduced the phosphorylation of Chk1 in response to 
APH and HU (Figure 1, D and E). Taken together, these tests indicate 
that this Chk1 reporter system recapitulates a faithful and specific 
checkpoint response.
After transfecting individual dsRNAs targeting each of 228 Dros-
ophila kinases into the reporter cells, we monitored the effect on the 
APH-induced phosphorylation of Chk1 by immunoblotting with an-
tiphosphopeptide antibodies. After multiple rounds of screening, 
we found approximately 16 dsRNAs that elicited a moderate to 
strong reduction in the phosphorylation of Chk1 (unpublished data). 
The results of the entire screen will be reported elsewhere. One 
positive dsRNA was directed against the casein kinase Gish. More-
over, dsRNAs against the casein kinases CG7094 and CG12147 
caused some reduction in the phosphorylation of Chk1 in the initial 
round of screening, although this effect was not apparent in a sec-
ondary round of screening. In general, casein kinases have a prefer-
ence for acidic substrates (Cheong and Virshup, 2011). Interestingly, 
the sequences around the critical phosphorylation sites in the CKAD 
of Claspin are also quite acidic. For example, the Xenopus CKAD 
repeat 1 sequence is MDELLDLCSGQF.
Identification of Drosophila Gish, a homologue of casein 
kinase 1γ, as a kinase that directly and specifically 
phosphorylates Claspin 
On the basis of these considerations, we decided to coexpress Gish 
as well as other Drosophila casein kinases in S2R+ cells along with a 
fragment containing the CKAD from Xenopus Claspin. We moni-
tored phosphorylation of this fragment by using antibodies that 
detect the Ser864-phosphorylated form of Claspin (Kumagai and 
Dunphy, 2003). In these experiments, we observed that cells overex-
pressing Gish exhibited strong phosphorylation of Claspin, but 
there was no phosphorylation in cells expressing CG7094 and 
CG12147 (Figure 2A). There was also significant phosphorylation of 
Claspin in cells expressing the CG9962 kinase. However, CG9962 
was negative in our dsRNA screen. To test if these kinases could 
phosphorylate Claspin directly, we expressed FLAG-tagged ver-
sions of these proteins in S2R+ cells. We isolated the kinases with 
anti-FLAG antibody beads, and then performed in vitro phosphory-
lation assays using the purified glutathione S-transferase (GST)-
CKAD fragment as substrate. We observed that only Gish could 
phosphorylate the GST-CKAD fragment efficiently, whereas the 
CG9962 kinase was considerably less effective (Figure 2, B and C). 
Taken together, these results indicate that Gish can phosphorylate 
Claspin both in vivo and in vitro.
Human CK1γ1, but not CK1γ2 or CK1γ3, phosphorylates 
Claspin in human cells
To investigate further the functional significance of these findings, 
we extended our studies to human cells. Among human proteins, 
Drosophila Gish is most similar to the CK1 gamma family of kinases 
(CK1γ), which includes three subfamilies (CK1γ1, CK1γ2, and CK1γ3; 
Zhai et al., 1995; Kusuda et al., 2000; Knippschild et al., 2005). Al-
though all three kinases exhibit a high degree of homology within 
the kinase domain, there are significant differences in their N- and 
C-terminal extensions, which suggests these proteins are function-
ally distinct. To test whether these kinases can directly phosphory-
late Claspin, we prepared recombinant versions of CK1γ1, CK1γ2, 
and CK1γ3 in Sf9 insect cells and then performed in vitro kinase 
assays (Figure 3A). In these experiments, we observed that all 
three kinases could phosphorylate the GST-CKAD fragment well 
(Figure 3B). In control experiments, we observed that recombi-
nant Chk1 could not phosphorylate this fragment significantly 
association of Chk1 with Claspin depends upon phosphorylation of 
Claspin on multiple conserved residues within its Chk1-activating 
domain (CKAD; Kumagai and Dunphy, 2003; Clarke and Clarke, 
2005; Lee et al., 2005; Chini and Chen, 2006; Bennett et al., 2008). 
These sites reside in highly conserved repeats of about ten amino 
acids (there are two such repeats in Xenopus Claspin and three in its 
human homologue). During a checkpoint response, serine and thre-
onine residues (e.g., Ser864 and Ser895 in Xenopus and Thr916, 
Ser945, and Ser982 in humans) within each repeat undergo phos-
phorylation. These phosphorylations create phosphopeptide 
sequences that dock with the catalytic domain of Chk1, thereby pro-
moting an increase in its kinase activity (Jeong et al., 2003). Muta-
genesis studies have indicated that both phosphorylations of Xeno-
pus Claspin and at least two out of three phosphorylations of the 
human protein are critical for the ultimate activation of Chk1 (Kuma-
gai and Dunphy, 2003; Bennett et al., 2008).
Despite the importance of these processes, the kinase respon-
sible for these modifications has not yet been identified. These 
phosphorylations are dependent upon ATR, but ATR does not 
phosphorylate these sites directly (Kumagai and Dunphy, 2003). 
Although it has been reported that Chk1 can phosphorylate Thr916 
of human Claspin in vitro (Chini and Chen, 2006), more recent evi-
dence has established that Chk1 is not responsible for the phos-
phorylation of the CKAD in vivo (Bennett et al., 2008). Thus, the 
identity of the Claspin-activating kinase has remained an open 
question. In this study, we have adopted a multifaceted approach 
to identify kinase(s) responsible for phosphorylation of the CKAD 
of Claspin. We first performed a whole-kinome RNAi screen in 
Drosophila S2R+ cells to identify kinases that influence the activa-
tion of Chk1 (Bettencourt-Dias et al., 2004). We followed through 
with these studies by carrying out various functional tests in both 
Drosophila S2R+ and human cells. Our results have indicated that 
one or more forms of casein kinase 1 gamma 1 (CK1γ1) can phos-
phorylate Claspin very effectively and regulate its ability to activate 
Chk1. Therefore, we have identified a novel player in the regula-
tory mechanisms through which metazoan cells safeguard genomic 
integrity.
RESULTS
Kinome-wide RNAi screen in Drosophila S2R+ cells
To identify the kinase(s) responsible for phosphorylation of the 
CKAD of Claspin, we carried out a kinome-wide RNA interference 
(RNAi) screen in Drosophila S2R+ tissue culture cells. Initially, we 
screened for kinases whose knockdown would diminish phosphory-
lation of Chk1. We reasoned that this approach might identify both 
the Claspin-regulatory kinase and other kinases that could affect the 
Chk1-activating pathway. Owing to technical limitations in detecting 
phosphorylation of the endogenous Drosophila Chk1 (Grapes), we 
decided to express an inducible version of Xenopus Chk1 in the 
S2R+ cells (Figure 1A). There are various high-quality antibodies 
available that detect the whole Xenopus Chk1 protein and phos-
phorylation of two residues involved in its activation (Thr314 and 
Ser344). As shown in Figure 1B, treatment of cells with either aphidi-
colin (APH) or hydroxyurea (HU) resulted in robust phosphorylation 
of the exogenously expressed Chk1. The kinetics of this activation 
closely mirrored that of the endogenous Chk1 in human cells 
(Figure 1C). For example, in both Drosophila and human cells, 
strong phosphorylation of Chk1 occurred within 5 min after addition 
of APH. To assess whether this phosphorylation involves the same 
regulators as in other organisms, we treated the cells with interfering 
dsRNAs directed against the Drosophila versions of ATR (Mei-41) 
and Claspin (CG32251/CG1326). We found that both dsRNAs 
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and kinase-dead (N169A mutant) forms of GST-tagged CK1γ1 in 
bacteria. We observed that the wild-type GST-CK1γ1 could phos-
phorylate Ser864 of Claspin efficiently, whereas the kinase-dead 
mutant was inactive (Figure 3D).
(Figure 3B). Moreover, we demonstrated that the CK1γ kinases 
could not phosphorylate a mutant form of the CKAD (2AG) in which 
the two critical phosphorylation sites (Ser864 and Ser895) had been 
changed to alanine (Figure 3C). Finally, we also produced wild-type 
FIGURE 1: Assay of DNA damage checkpoint responses in Drosophila S2R+ cells. (A) Diagram showing the Xenopus 
Chk1 reporter construct used in Drosophila S2R+ cells. MT, metallothionein promoter; NLS, nuclear localization signal. 
(B) Expression of the Chk1-GST fusion protein was induced for 16 h and cells were treated in the absence or presence of 
either APH (10 μg/ml for 10 min) or HU (2 mM for 16 h). Whole-cell lysates were prepared and immunoblotted with 
antibodies against the Ser344-phosphorylated form of Xenopus Chk1 (Top) or GST (Bottom). (C) The Drosophila 
reporter cells and human U2OS cells were treated with APH for the indicated length of times. Whole-cell lysates were 
immunoblotted with the indicated antibodies against phospho-Chk1, GST, and human Chk1. (D and E) Phosphorylation 
of Chk1 in Drosophila cells is dependent on ATR and Claspin. Drosophila reporter cells were incubated with dsRNAs 
against Mei-41 (M) or Claspin (Cl) for 96 h. Subsequently, cells were treated with APH or HU, as in (B). Whole-cell lysates 
were prepared and analyzed by immunoblotting. dsRNA against firefly luciferase (F) was used as a control.
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levels in human U2OS cells. Concomitantly, we also introduced the 
GST-CKAD fragment into the cells. We observed that only cell lines 
expressing CK1γ1 could phosphorylate the fragment of Claspin 
above the background level found in cells containing no recombi-
nant kinase (Figure 3E, lanes 2, 4, 6, and 8). Moreover, cells express-
ing exogenous CK1γ1 also displayed a modest increase in phospho-
rylation of the CKAD in response to APH (Figure 3E, lanes 3, 5, 7, 
and 9).
CK1γ1 is required for the checkpoint-induced 
phosphorylation of Claspin and activation of Chk1 
in human cells
To further evaluate the role of CK1γ1 in the phosphorylation of 
Claspin, we utilized small interfering RNAs (siRNAs) to knock down 
the expression of the various CK1γ kinases in human cells. We mon-
itored the efficiency of siRNA knockdown at both the mRNA and 
protein level for CK1γ1 and CK1γ2 (Figure 4A and Supplemental 
Figure S1, A, B, and D–F). Due to the fact that a suitable antibody 
for detection of CK1γ3 is not available, we were able to monitor only 
the mRNA level for this kinase (Figure S1C). As an initial test for the 
effect of the CK1γ1 knockdown, we examined phosphorylation of 
the transiently expressed form of the Xenopus CKAD in human 
U2OS cells. For this purpose, we generated a line of U2OS cells in 
which expression of this fragment is under control of a doxycycline-
inducible promoter. We observed a large increase in the phospho-
rylation of the CKAD fragment within 5 min after addition of APH, 
which correlated well with the activation of Chk1 (Figure S1G). 
We found that this phosphorylation could be abolished almost 
completely if the cells had been transfected with CK1γ1 siRNA 
(Figure 4B). In contrast, when the cells were transfected with siRNAs 
against CK1γ2 or CK1γ3, there was no such reduction (Figure 4, C 
and D). We could also observe reduced phosphorylation of Claspin 
with multiple CK1γ1 siRNAs, which suggests the results are not due 
to off-target effects (Figure 4E). Finally, depletion of CK1γ1 (as well 
as that of CK1γ2 or CK1γ3) did not affect the cellular levels of other 
regulators of Chk1, such as ATR, Claspin, TopBP1, and Rad17 
(Figure S1, H and I). Thus, removal of CK1γ1 does not generally af-
fect components of the ATR-mediated regulatory pathway.
Since phosphorylation of Claspin is necessary for binding to 
Chk1, we also examined whether knockdown of CK1γ1 would affect 
the Claspin–Chk1 interaction. For this purpose, we performed pull-
down experiments with the GST-CKAD fragment, which is known to 
interact well with Chk1. As expected, there was increased binding of 
Chk1 to the GST-CKAD in cells treated with APH (Figure 4F). By 
contrast, this increase was abrogated in cells transfected with CK1γ1 
siRNA. Altogether, our data indicate CK1γ1, but not CK1γ2 or 
CK1γ3, is a specific kinase responsible for the checkpoint-induced 
phosphorylation of Claspin in human cells.
To pursue these findings further, we examined the effect of abla-
tion of CK1γ1 on the ultimate activation of Chk1. We observed that 
removal of CK1γ1 by siRNA treatment from U2OS cells substantially 
diminished the phosphorylation of Chk1 (Figure 5, A and B). The 
reduction was similar to that observed in cells treated with siRNA 
directed against TopBP1, the upstream activator of ATR–ATRIP. By 
contrast, depletion of CK1γ2 or CK1γ3 in the same experiments had 
no effect on phosphorylation of Chk1. We observed a reduction in 
the phosphorylation of Chk1 following treatment with three differ-
ent siRNAs against CK1γ1 (Figure 5B). Moreover, we obtained very 
similar results in a different cell line, namely, HeLa cells (Figure S2A–
C). Finally, as a complementary means to confirm the effect of the 
siRNAs, we also generated a series of endoribonuclease-prepared 
siRNAs (esiRNAs), which are a mixture of siRNA oligonucleotides 
generated in vitro by cleavage of long double-stranded RNA with 
We pursued these findings by comparing the abilities of these 
kinases to phosphorylate Claspin in human cells. We proceeded to 
express recombinant forms of CK1γ1, CK1γ2, and CK1γ3 at similar 
FIGURE 2: The CKAD sites of Claspin are specifically phosphorylated 
by a Drosophila homologue of CK1γ. (A) The GST-tagged Claspin 
CKAD fragment was expressed in Drosophila S2R+ cells in the absence 
(lanes 1 and 2) or presence (lanes 3–9) of individual FLAG-tagged 
Drosophila casein kinases. After 48 h, total cell lysates were prepared 
and immunoblotted with antibodies against Ser864-phosphorylated 
Claspin, GST, or the FLAG epitope. In lane 2, cells were treated with 
APH for 10 min prior to lysis. (B) In vitro kinase assay. Purified 
GST-CKAD peptide was incubated with the indicated FLAG-tagged 
Drosophila casein kinases immunoprecipitated from S2R+ cell lysates. 
The reactions were subjected to SDS–PAGE and immunoblotted with 
antibodies against Ser864-phosphorylated Claspin, GST, or the FLAG 
epitope. (C) Quantitation of the data from (B), expressed as a ratio of 
Ser864-phosphorylated Claspin to the total amount of each kinase.
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RNase III. As shown in Figure S2D, esiRNAs 
directed against CK1γ1 strongly inhibited 
phosphorylation of Chk1 but comparably 
generated esiRNAs against CK1γ2 and 
CK1γ3 had no effect.
Among the various substrates of ATR–
ATRIP, Chk1 appears to be unique in its 
need for assistance by Claspin (Liu et al., 
2006; Smits et al., 2010). Accordingly, we 
asked whether ablation of CK1γ1 might af-
fect other substrates of ATR–ATRIP. For this 
purpose, we examined the ATR-dependent 
phosphorylation of Rad17 on Ser645 (Bao 
et al., 2001; Post et al., 2001). As antici-
pated, depletion of TopBP1 diminished 
phosphorylation of Rad17 in response to 
APH (Figure S2E). On the other hand, re-
moval of CK1γ1 (or CK1γ2 and CK1γ3) had 
no effect on this phosphorylation. This result 
lends further support to the hypothesis that 
CK1γ1 acts specifically at the level of the 
Claspin–Chk1 interaction. This finding also 
indicates depletion of CK1γ1 does not gen-
erally perturb the ATR-mediated signaling 
pathway.
Depletion of CK1γ1 leads to multiple 
checkpoint defects
Once we established that CK1γ1 is respon-
sible for the phosphorylation of Claspin and 
activation of Chk1, we sought to extend our 
studies by examining the roles of CK1γ1 in 
various aspects of cell physiology, including 
checkpoint responses. We noticed deple-
tion of CK1γ1 eventually led to a decrease in 
cellular proliferation (Figures 6A and S3A). 
The effect was relatively mild within 48 h af-
ter siRNA transfection, but became more 
noticeable by 72 h. To analyze this effect in 
more detail, we examined cell cycle pro-
gression in the siRNA-treated cells. By per-
forming flow cytometry, we observed that 
the percentage of cells in G2/M remained 
about the same upon depletion of CK1γ1, 
but there appeared to be a significant drop 
in the percentage of S phase cells as well as 
an increase in G1 cells (Figure 6B). As an-
other means to examine the effect on S 
phase, we labeled cells with 5-ethynyl-2′-
deoxyuridine (EdU) and detected the EdU-
positive cells by flow cytometry in order to 
assess DNA replication. In these experi-
ments, we observed an approximately 50–
60% reduction of incorporated EdU in 
CK1γ1-depleted cells compared with con-
trol cells (Figure 6C).
To examine potential causes for the de-
crease in DNA replication, we asked whether 
depletion of CK1γ1 might lead to the occur-
rence of DNA damage. For this purpose, we 
stained cells with antibodies directed against 
Ser139-phosphorylated H2AX, known as 
γ-H2AX, which is a well-known marker for 
FIGURE 3:  Human CK1γ1 phosphorylates the Claspin CKAD sites both in vitro and in human 
cells. (A) Tagged versions of human CK1γ1, CK1γ2, and CK1γ3 proteins were purified from Sf9 
insect cells with nickel agarose beads, resolved by SDS–PAGE, and stained with Coomassie 
Brilliant Blue (CBB). (B) In vitro kinase assays. Purified GST-CKAD was incubated in vitro with no 
added kinase (lane 1), the indicated forms of CK1γ (lanes 2–4), or Xenopus Chk1-His6-GST (lane 
5), as described in Materials and Methods. The samples were subjected to SDS–PAGE and 
immunoblotted with antibodies against Ser864-phosphorylated Xenopus Claspin (Top) or 
stained with Coomassie Brilliant Blue (Bottom). (C) In vitro kinase assays were performed as 
described in (B) with no substrate (lanes 1–3), wild-type GST-CKAD (lanes 4–6), or a mutant of 
the substrate in which Ser864 and Ser895 were changed to alanine (2AG; lanes 7–9). (D) In vitro 
kinase assays were performed as described in (B). Purified wild-type GST-CK1γ1 (WT) and its 
kinase-dead (KD) mutant were incubated in the absence (lanes 1–2) or presence (lanes 4–5) of 
the GST-CKAD substrate. For lane 3, the incubation contained substrate, but not any 
recombinant kinase. (E) Only CK1γ1 phosphorylates Claspin well in human cells. CK1γ1, CK1γ2, 
and CK1γ3 were coexpressed with the GST-CKAD in human U2OS cells. Cells were incubated in 
the absence or presence of APH for 10 min as indicated. Cell lysates were prepared and 
immunoblotted with anti-P-Ser864, anti-GST, and anti-FLAG antibodies.
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FIGURE 4: siRNA knockdown of CK1γ1, but not CK1γ2 or CK1γ3, abolishes phosphorylation of Claspin in human cells. 
(A) Reduction of CK1γ1 protein levels by siRNA. U2OS cells were transfected with control or CK1γ1 siRNA for 48 h. 
Whole-cell lysates were prepared and subjected to immunoprecipitation with control (lane 1) or anti-CK1γ1 antibodies 
(lanes 2–3). The immunoprecipitates were subjected to immunoblotting with anti-CK1γ1 antibodies (Top). The asterisk 
denotes a nonspecific background band. The total level of α-tubulin in each lysate was also determined by 
immunoblotting (Bottom). (B) U2OS cells harboring an inducible form of the GST-CKAD peptide were treated with 
various amounts of CK1γ1 siRNA (0.5–50 nM) for 48 h. Cells were incubated in the absence (lane 1) or presence (lanes 
2–9) of APH for 10 min. Expression of the GST-CKAD was induced with doxycycline 16 h before addition of APH. 
Whole-cell lysates were immunoblotted as indicated. (C) U2OS cells were incubated with no siRNA (lanes 1 and 2), 
TopBP1 siRNA (lane 3), CK1γ2 siRNA #1 (lane 4), or control siRNA for 48 h, and incubated in the absence (lane 1) or 
presence of APH for 10 min (lanes 2–5). Expression of the GST-CKAD was induced as described in (B). Whole-cell lysates 
were immunoblotted as indicated. (D) Same as (C), except CK1γ3 siRNA #2 was used for lane 4. (E) U2OS cells were 
treated for 48 h with no siRNA (lanes 1 and 2), TopBP1 siRNA (lane 3), CK1γ1 siRNA #1 (lane 4), CK1γ1 #2 (lane 5), CK1γ1 
#3 (lane 6), all three CK1γ1 siRNAs (lane 7), or control siRNA (lane 8). Cells were incubated in the absence (lane 1) or 
presence (lanes 2–8) of APH for 10 min. Expression of the GST-CKAD was induced as described in (B). Total cell lysates 
were prepared and immunoblotted with the indicated antibodies. Band signals for phospho-Claspin and Claspin were 
detected and quantitated by using the Odyssey Infrared Imaging System (Bottom). Blotting membranes were also 
processed for standard ECL with secondary anti-rabbit antibodies (Top). (F) GST pulldown experiments. U2OS cells were 
treated with no siRNA (lanes 1 and 2), control siRNA (lane 3), or CK1γ1 siRNA #2 (lane 4) for 48 h and then incubated in 
the absence (lanes 1 and 2) or presence (lanes 3 and 4) of APH for 10 min. Expression of the GST-CKAD was either not 
induced (lane 1) or induced with doxycycline (lanes 2–4) 16 h before addition of APH. Whole-cell lysates were prepared 
and incubated with glutathione beads. Bead-associated proteins (top three panels) and whole-cell lysates (bottom two 
panels) were immunoblotted with the indicated antibodies.
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FIGURE 5:  CK1γ1 is required for the damage-induced 
phosphorylation of Chk1. (A) U2OS cells were incubated for 48 h with 
no siRNA (lanes 1 and 2), control siRNA (lanes 3, 4, and 9), TopBP1 
siRNA (lane 5), CK1γ1 siRNA #2 (lane 6), CK1γ2 siRNA #1 (lane 7), and 
CK1γ3 siRNA #2 (lane 8). Cells were incubated in the absence (lanes 1 
and 3) or presence (lanes 2 and 4–9) of APH for 10 min. Whole-cell 
lysates were immunoblotted with antibodies that detect phospho-
Chk1 Ser345, phospho-Chk1 Ser317, Chk1 protein, and tubulin. 
(B) U2OS cells were treated for 48 h with no siRNA (lanes 1 and 2), 
TopBP1 siRNA (lane 3), CK1γ1 siRNA #1 (lane 4), CK1γ1 #2 (lane 5), 
CK1γ1 #3 (lane 6), all three CK1γ1 siRNAs (lane 7), or control siRNA 
(lane 8). Cells were incubated in the absence (lane 1) or presence 
(lanes 2–8) of APH for 10 min. Whole-cell lysates were prepared and 
immunoblotted with antibodies that detect phospho-Chk1 Ser317, 
Chk1 protein, and tubulin. Band signals for phospho-Chk1 and Chk1 
were detected and quantitated by using the Odyssey Infrared 
Imaging System (Bottom). Blotting membranes were also processed 
for standard ECL, with secondary anti-rabbit or anti-mouse 
antibodies (Top).
the presence of damaged DNA (Paull et al., 2000). We observed the 
highly elevated presence of nuclear foci containing γ-H2AX in 
CK1γ1-depleted cells compared with control cells (Figures 6D and 
S3B). Thus, lack of CK1γ1 apparently leads to the accumulation of 
damage without exposure to any exogenous damaging agent. As 
expected from published results, depletion of Chk1 also resulted in 
elevated staining for γ-H2AX (Paulsen et al., 2009). On the other 
hand, removal of CK1γ2 did not have this effect. It is well known 
that the presence of damaged DNA suppresses DNA replication. 
Therefore, chronic DNA damage in CK1γ1-depleted cells may at 
least partially explain the reduced levels of DNA synthesis. However, 
we do not have direct evidence for this possibility.
We next examined various physiological responses to genotoxic 
stress following ablation of CK1γ1. Toward this end, we examined 
cell survival upon treatment with replication inhibitors. In one type 
of assay, we treated cells with HU for 24 h, and then examined the 
ability of the cells to form colonies upon removal of the drug. We 
also monitored survival of cells incubated continuously with various 
doses of APH. In both types of assays, we observed depletion of 
CK1γ1 significantly compromised the ability of cells to withstand 
replication stress (Figure 6, E and F). In another line of experiments, 
we monitored recovery of replication forks after stalling. For this pur-
pose, we used the experimental design shown in Figure 6G. We first 
challenged cells with a transient (10 min) treatment with APH to 
block DNA replication. Subsequently, we removed the drug, al-
lowed the cells to recover for 60 min, and finally performed pulse-
labeling with EdU to assess the replicative capacity of the cells. We 
observed control cells exhibited nearly complete recovery from the 
challenge to DNA replication, whereas the CK1γ1-depleted cells 
were not able to recover effectively (Figure 6, G and H). This result 
further supports a role for CK1γ1 in mediating a proper DNA dam-
age response in the S phase of the cell cycle.
Finally, we examined whether CK1γ1 also plays a role in mediat-
ing the G2/M checkpoint. To test this possibility, we irradiated con-
trol or CK1γ1-depleted cells with ultraviolet (UV) light, labeled the 
cells with antibodies against the M-phase marker phospho-histone 
H3, and quantitated the staining by flow cytometry. In these experi-
ments, we observed the expected large reduction in the mitotic 
marker in the irradiated control cells, but this response was substan-
tially defective in the CK1γ1-depleted cells (Figure 6, I and J). As 
part of these experiments, we also verified that depletion of CK1γ1 
also compromised activation of Chk1 in response to UV (Figure 
S3C). Together, our results indicate that CK1γ1 plays an important 
role in regulating DNA damage checkpoint responses in both the S 
and G2/M phases.
Multiple CK1γ1 isoforms contribute to the phosphorylation 
of Claspin
As part of these studies, we sought to rescue the effects of depletion 
of CK1γ1 by introducing an siRNA-resistant form of CK1γ1 into hu-
man cells. However, as shown in Figure S4A, we were able to obtain 
only a partial rescue of these phenotypes in stable lines of U2OS 
cells harboring an inducible, siRNA-resistant version of the published 
form of CK1γ1 (Zhai et al., 1995; Kusuda et al., 2000). An important 
consideration for these experiments is that there appear to be mul-
tiple isoforms of CK1γ1 in human cells. After performing a system-
atic search of the human Expressed Sequence Tags database, we 
could readily identify numerous potentially distinct forms of CK1γ1. 
After aligning the sequences, we noticed that all of them contained 
the same sequence at their 5′ end (which encodes the kinase do-
main), but that their 3′ ends were substantially different. After care-
fully analyzing possible polyadenylation signal sites and stop codons 
and performing comparisons with genomic DNA data, we identified 
at least four potential new isoforms of CK1γ1. On the basis of these 
sequences, we designed primers specific to each isoform and were 
able to amplify three out of the four isoforms from human U2OS 
cells by reverse transcription PCR (RT-PCR; see sequence alignments 
in Figure S4B). For clarity of presentation, we have designated the 
published version of CK1γ1 as isoform A, and the remaining three 
new forms that we were able to isolate as B, C, and D.
To evaluate the differences between these forms, we ex-
pressed these proteins as FLAG-tagged fusions in human cells 
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dence has indicated the presence of Claspin in this complex en-
hances the ability of ATR–ATRIP to phosphorylate Chk1 on key resi-
dues necessary for the ultimate activation of Chk1 (Kumagai et al., 
2004; Lindsey-Boltz et al., 2009). Thus, the kinase that phosphory-
lates Claspin on the CKAD plays a key role in this pathway.
To address the identification of this kinase(s) systematically, we 
initially performed a kinome-wide RNAi screen in Drosophila S2 
cells. Various RNAi screens in these cells have been used to identify 
numerous regulators in diverse cellular pathways (Bettencourt-Dias 
et al., 2004; Bjorklund et al., 2006; Boutros and Ahringer, 2008). For 
our purposes, the fact that Drosophila contains approximately one-
third as many kinases as humans was a considerable advantage. S2 
cells appear to possess checkpoint-signaling pathways generally 
similar to those in other metazoan cells (de Vries et al., 2005; Yi 
et al., 2009). In particular, the Drosophila Chk1 homologue Grapes 
exhibits a conserved checkpoint function in S2 cells. It functions 
downstream of Mei-41 (the Drosophila homologue of ATR) and is 
critical for a proper checkpoint response to genotoxic stress.
Nonetheless, the reagents available for the study of checkpoint 
responses in Drosophila S2 cells are still relatively limited. To circum-
vent this problem, we introduced the Xenopus version of Chk1 into 
the Drosophila cells as a more readily traceable marker to monitor 
the checkpoint response. We were able to establish a system in 
which phosphorylation of this reporter could be induced following 
treatment with a variety of replication inhibitors. Moreover, this re-
sponse seems to have molecular features similar to those present in 
vertebrate cells. For example, RNAi-mediated knockdown of Droso-
phila homologues of ATR and Claspin abolished checkpoint-depen-
dent phosphorylation of the exogenously introduced Chk1 reporter 
molecule.
The results of our screen indicated that knockdown of several 
casein kinases led to the reduced phosphorylation of Chk1. Follow-
ing this lead, we next employed a candidate-based cDNA overex-
pression approach to further pinpoint a specific kinase that can di-
rectly phosphorylate the CKAD of Claspin. From these tests, we 
eventually found that Drosophila Gish, a homologue of CK1γ, could 
phosphorylate the CKAD of Claspin quite effectively both in vitro 
and in the Drosophila tissue culture cells. At this juncture, we chose 
to extend our studies to human cells. Interestingly, humans possess 
three different versions of CK1γ, namely, CK1γ1, CK1γ2, and CK1γ3. 
All three proteins have very similar central kinase domains but are 
significantly different in their N- and C-terminal extensions. We ob-
served that all three kinases could phosphorylate the CKAD rela-
tively well in vitro. However, our further characterizations established 
that CK1γ1 appears to be the form primarily responsible for the 
phosphorylation of CKAD in human cells. Upon expression in hu-
man cells, only CK1γ1 could phosphorylate the CKAD of Claspin in 
vivo. More importantly, siRNA-mediated knockdown of CK1γ1 re-
sulted in greatly reduced phosphorylation of Claspin, whereas 
knockdowns of CK1γ2 and CK1γ3 did not have a significant effect. 
As expected from the known function of the phosphorylation of 
Claspin, cells with diminished levels of CK1γ1 were greatly compro-
mised in their ability to carry out the activation of Chk1 in response 
to a variety of genotoxic agents, including APH, HU, and UV. Fur-
thermore, these cells had the physiological defects characteristic of 
cells with impairment of the Chk1-mediated signaling pathway. In 
particular, these cells showed reduced survival following treatment 
with genotoxic agents, impaired recovery of stalled replication forks, 
a defective G2/M checkpoint response, and spontaneous DNA 
damage in the absence of exogenous stress. Taken together, our 
results indicated CK1γ1 is an important regulator in Chk1-mediated 
cellular checkpoint responses.
and examined their intracellular localization by indirect immunofluo-
rescence (Figure 7A). Interestingly, their localizations appeared to 
be quite distinct. We observed that immunofluorescence staining 
for isoform A covered the entire cell with a prominent staining of the 
plasma membrane. This distribution is consistent with the fact that 
isoform A contains a lipid attachment sequence near the C-terminal 
end of the protein that would confer membrane localization. By con-
trast, isoforms B and C exhibited both nuclear and cytoplasmic 
staining, whereas isoform D appeared to reside only in the cyto-
plasm. None of the isoforms B, C, and D appeared to exhibit mem-
brane localization, which is consistent with the fact that all three 
proteins lack the lipid attachment sequence.
We then compared the activities of these different proteins in 
phosphorylating the GST-CKAD fragment of Claspin upon coex-
pression in human cells (Figure 7B). In this in vivo assay, phosphory-
lation of Claspin by isoform A was comparatively weak. Significantly, 
however, both isoforms B and C were very effective in phosphorylat-
ing S864 of Claspin. We could not observe good phosphorylation 
with isoform D, but it was difficult to express this protein at high 
levels. As another assessment of specificity, we also coexpressed 
the GST-CKAD with other members of the casein kinase family 
(namely, CK1α , two different forms of CK1δ, and CK1ε). As shown 
in Figure S4C, none of these kinases could phosphorylate S864 of 
Claspin significantly in a side-by-side comparison with CK1γ1 
(isoform C).
In an attempt to dissect the relative contributions of these iso-
forms to phosphorylation of Claspin, we designed isoform-specific 
siRNAs against one of the nuclear isoforms (isoform C). Unfortu-
nately, the unique sequence of isoform B is not long enough for 
design of multiple nonoverlapping siRNAs. We observed that de-
pletion of isoform C by two distinct siRNAs resulted in an approxi-
mately 50% inhibition of the checkpoint-dependent phosphoryla-
tion of Claspin and Chk1 (Figure 7, C–E). These findings suggest 
isoform C is partially responsible for the phosphorylation of Claspin, 
and imply that one or more of the other isoforms would carry out the 
remainder of the phosphorylation.
Finally, we sought to rescue the decreased phosphorylation of 
Claspin and Chk1 in CK1γ1-depleted cells by introducing siRNA-
resistant versions of one or more isoforms of CK1γ1 into the cells. 
For this purpose, we generated lentiviruses encoding siRNA-resis-
tant versions of isoforms A, B, and C. As shown in Figure 7, F and G, 
coinfection of siRNA-treated cells with three lentiviruses encoding 
all three isoforms resulted in good rescue of both the phosphoryla-
tion of Claspin (monitored with the exogenously expressed GST-
CKAD) and the phosphorylation of Chk1 in response to treatment 
with APH. In various experiments, we obtained the best rescue with 
this combination of viruses. We obtained a similar rescue of the 
phosphorylation of Chk1 in cells lacking the exogenously expressed 
GST-CKAD (unpublished data). Furthermore, these rescued cells 
also exhibited a significantly restored cell cycle profile and G2/M 
checkpoint (Figure S5, A and B). Taken together, these results sug-
gest that multiple isoforms of CK1γ1 are necessary for the normal 
phosphorylation of Claspin.
DISCUSSION
In this study, we sought to resolve the molecular basis of a key step 
in the checkpoint-dependent activation of Chk1 in response to ge-
nomic stress. The activation of Chk1 involves phosphorylation-de-
pendent docking of Chk1 with its cognate mediator protein (Claspin) 
and recognition of the resulting Claspin–Chk1 complex by ATR–
ATRIP. In particular, phosphorylation of Claspin on multiple residues 
in its CKAD mediates the binding of Chk1. Direct biochemical evi-
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FIGURE 6: Depletion of CK1γ1 results in abnormal cell growth, increased DNA damage, and failure in checkpoint 
responses. (A) Cell numbers in cultures of U2OS cells were determined at the indicated times following transfection with 
control siRNA or CK1γ1 siRNA #2. (B) Cell cycle distribution. Asynchronous culture of U2OS cells treated with control 
siRNA or CK1γ1 siRNA #2 for 48 h were stained with 7-AAD, and DNA content was analyzed by flow cytometry. 
Percentages of cells in each phase of the cell cycle were quantified with the FlowJo program (Ashland, OR). (C) DNA 
replication. U2OS cells treated with control siRNA or CK1γ1 siRNA #2 for 48 h, pulse-labeled with EdU for 45 min, 
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ATR-mediated signaling by disrupting the interaction between 
Claspin and Chk1 (Leonard et al., 2008).
It will be important to understand the mechanisms that control 
the phosphorylation of Claspin by CK1γ1 (see Figure 7H). It is known 
that phosphorylation of the CKAD in Xenopus egg extracts is de-
pendent upon ATR. However, ATR itself is unable to phosphorylate 
the critical sites in the CKAD directly. One possibility would be that 
ATR might somehow regulate the activity of CK1γ1. However, we 
have been able to detect only a subtle increase in the activity of 
CK1γ1 in response to genomic stress. Moreover, when we mutated 
the only apparent potential target site for ATR (Ser361) to Ala in 
CK1γ1, we could not observe a change in its kinase activity toward 
the CKAD upon coexpression in U2OS cells (unpublished data). An-
other possibility is that ATR might regulate the accessibility of 
Claspin to CK1γ1. Further studies will be required to understand the 
dynamics of this phosphorylation.
In summary, we identified a conserved casein kinase, Gish/
CK1γ1, from Drosophila and humans as a specific enzyme that con-
trols phosphorylation of the CKAD of Claspin. Functional studies 
have revealed that this kinase is critical for mediating activation of 
Chk1 and ensuring a proper checkpoint response under conditions 
of genotoxic stress. Further studies of its regulation and function 
should help us gain more insight into the molecular basis of check-
point responses.
MATERIALS AND METHODS
Drosophila cell culture
Drosophila S2R+ cells were purchased from the Drosophila Genomics 
Resource Center (Bloomington, IN) and cultured at room tempera-
ture (23°C) in Schneider’s Drosophila culture medium (Invitrogen, 
Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS; 
Invitrogen) and 100 U/ml penicillin and 100 μg/ml streptomycin. 
Stable S2R+ cell lines expressing the pMT-Chk1-NLS-GTS reporter 
were generated by cotransfection of the reporter plasmid with the 
pCoHygro plasmid (19:1) and selection with 300 μg/ml hygromycin 
for ∼21 d. Expression of the reporter gene was induced with CuSO4 
(500 μM) for 16 h. DNA replication blocks were induced by treating 
cells with APH (10 μg/ml) for 10 min or HU (2 mM) for 16 h.
Plasmid transfection and dsRNA-mediated RNA interference 
in Drosophila cells
Plasmid DNA transfections were performed using FuGENE 6 re-
agent (Roche, Indianapolis, IN) according to the manufacturer’s in-
structions. Briefly, S2R+ cells (0.6 × 106) were seeded in 12-well 
The casein kinase 1 family of serine/threonine kinases is highly 
conserved and ubiquitously expressed. The functions of CK1 en-
compass a wide variety of processes, including cell proliferation, cell 
division, apoptosis, circadian rhythms, and others (Gross and 
Anderson, 1998; Knippschild et al., 2005; Cheong and Virshup, 
2011). In mammals, this family contains at least seven members (α, 
b, δ, ε, γ1, γ2, and γ3) with multiple splicing variants. All of the CK1 
proteins share significant homology in the central kinase domain 
(53–98% identical), but differ significantly in the flanking N- and C-
terminal sequences, which most likely confer unique properties to 
the various kinases. In the case of CK1γ1, we identified and isolated 
multiple splicing variants of this kinase from human U2OS cells. 
These isoforms contain distinct C-terminal sequences (ranging from 
3 to 106 amino acids), display discrete subcellular localizations, and 
exhibit differences in their abilities to phosphorylate the CKAD. A 
similar phenomenon has also been observed in various organisms in 
the case of CK1α, which contains four types of isoforms with distinct 
localizations and kinase activities (Zhang et al., 1996; Green and 
Bennett, 1998; Burzio et al., 2002). These findings strongly suggest 
various isoforms of CK1 may participate in distinct cellular activities 
due to differences in access to and/or affinity for substrates.
Interestingly, we initially found it difficult to achieve good rescue 
of CK1γ1-depleted cells with vectors encoding an siRNA-resistant 
version of the major published form of CK1γ1. However, as described 
in the last part of Results, there are multiple forms of CK1γ1 in human 
cells. We were able to clone and express three additional versions of 
CK1γ1, which we designated as isoforms B, C, and D to distinguish 
them from the published form (isoform A). In cellular localization 
studies, we found that isoform A had the expected prominent local-
ization to cell membranes (Davidson et al., 2005). However, isoforms 
B and C resided in both the nucleus and cytoplasm, whereas isoform 
D was mainly cytoplasmic. In coexpression studies, we found that 
isoforms A, B, and C (but not D) could phosphorylate the CKAD of 
Claspin, although isoforms B and C were more effective than isoform 
A in this in vivo assay. Ultimately, we were able to rescue depletion of 
CK1γ1 by introducing siRNA-resistant forms of isoforms A, B, and C 
into the cells. It is straightforward to understand how the nuclear 
isoforms could regulate Claspin, but it is intriguing that a membrane-
bound enzyme is also partially responsible. Conceivably, some frac-
tion of this isoform could be absent from the membrane. It is also 
possible that Claspin could shuttle between the nucleus and cyto-
plasm and thus be subject to regulation by enzymes in both loca-
tions. In this regard, a recent study has shown that perturbed cell-
surface signaling through the Sonic Hedgehog (Shh) pathway inhibits 
stained with 7-AAD, and analyzed by flow cytometry. Percentages of EdU-positive cells are indicated. (D) Assay for 
damaged DNA. U2OS cells were treated with control siRNA, CK1γ1 siRNA #2, CK1γ2 siRNA #1, or Chk1 siRNA for 48 h. 
Cells were pulse-labeled with EdU for 45 min. Immunofluorescence staining was performed by incubating cells with 
Hoechst dye to detect DNA, Click-iT reagent to detect incorporated EdU, and antibodies against γ-H2AX to detect 
DNA damage foci. Scale bar: 30 μm. (E) Colony survival assay. U2OS cells were treated with control siRNA, CK1γ1 siRNA 
#2, CK1γ2 siRNA #1, or Chk1 siRNA for 48 h, and then incubated with the indicated doses of HU for 24 h. The cells were 
washed, trypsinized, and then replated at low density. Surviving colonies were stained with crystal violet and counted 
after 8 d. (F) Killing curve. U2OS cells treated with control siRNA or CK1γ1 siRNA #2 were grown in the presence of 
different doses of APH. Cells were stained with crystal violet after 6 d. Staining intensities were measured with the 
Odyssey Imaging System, and the relative percentages of surviving cells were plotted. (G) S-phase checkpoint. In the 
experimental scheme summarized on top, U2OS cells transfected with control siRNA or CK1γ1 siRNA #2 were first 
treated with APH for 10 min, allowed to recover for 60 min, and finally labeled with EdU for 30 min. Representative 
images showing the incorporation of EdU before and after treatment with APH are shown in the bottom. Scale bar: 50 
μm. (H) Percentages of EdU-positive cells in (G) were counted and plotted. (I) G2/M checkpoint. U2OS cells transfected 
with control siRNA or CK1γ1 siRNA #2 were irradiated with UV (20 J/m2), and then incubated for 1 h before fixation. 
Cells were stained with anti-phospho-histone H3 antibodies conjugated with Alexa Fluor 488 dye and with 7-AAD. (J) 
Percentages of mitotic cells from (I) were determined by flow cytometry.
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FIGURE 7: Contribution of multiple CK1γ1 isoforms to the phosphorylation of Claspin. (A) Distinct localizations of 
various isoforms of CK1γ1 in human cells. U2OS cells expressing FLAG-tagged CK1γ1 isoforms were processed for 
indirect immunofluorescence with anti-FLAG antibodies. Scale bar: 30 μm. (B) Differential phosphorylation of Claspin by 
CK1γ1 isoforms. The CKAD fragment of Claspin was coexpressed with different isoforms of CK1γ1 in human U2OS cells. 
Whole-cell lysates were prepared and analyzed by immunoblotting. (C) Isoform-specific siRNAs. U2OS cells expressing 
the FLAG-tagged CK1γ1 isoform C were treated with a control siRNA, CK1γ1 siRNA #2, or two isoform-specific siRNAs 
(#71 and #156). Note that siRNA #156, which targets the coding/3′-UTR junction region of CK1γ1 isoform C, only 
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vector, which encodes an N-terminal FLAG tag. siRNA-resistant 
versions of CK1γ1 were created through introduction of silent mu-
tations into three nucleotides in the middle of siRNA-targeting re-
gions by site-directed mutagenesis.
siRNAs and esiRNAs
Stealth siRNA duplexes specific for CK1 gamma kinases and a con-
trol siRNA (low GC) were purchased from Invitrogen. The sense 
strand sequences of these siRNAs are listed in Supplemental Table 
S1. These CK1γ1 siRNAs are directed against common regions pres-
ent in all isoforms. esiRNAs were produced in vitro essentially by 
following the protocol kindly provided by Eric Lau and Wei Jiang 
(Burnham Institute, La Jolla, CA; Lau et al., 2006).
Immunoblotting and antibodies
Immunoblotting and enhanced chemiluminescence (ECL) were per-
formed by standard methods. For detection of phosphorylation sig-
nals, 2 mM Na3VO4 and 20 mM NaF were included in all immunob-
lotting solutions to block potential phosphatase activities. For 
quantification of immunoblotting signals, membranes were stripped 
and blotted with IRDye-800- or IRDye-680-conjugated secondary an-
tibodies and scanned with the Odyssey Infrared Imaging System 
(LI-COR Biosciences, Lincoln, NE).
For generation of anti-CK1γ1 antibodies, the sequence en-
coding the full-length human CK1γ1 isoform A was cloned into 
the pET30a vector and expressed in bacterial cells. Recombinant 
protein was solubilized in 6 M urea and purified with nickel aga-
rose beads. This protein was used to immunize rabbits, and the 
generated antibody was affinity purified. Because the expression 
level of CK1γ1 in U2OS cells is low, we carried out immunopre-
cipitation and then immunoblotting on a relatively large scale for 
detection of endogenous CK1γ1. Whole-cell lysates were pre-
pared in TEB150 buffer with phosphatase and protease inhibi-
tors as described above. Next, whole-cell lysates were incubated 
with anti-CK1γ1 antibodies coupled to the protein-A Dynabeads 
(Invitrogen) for 90 min at 4°C. Finally, the beads were washed 
two times with Buffer A (10 mM HEPES-KOH, pH 7.5, 150 mM 
NaCl, 0.5% Nonidet P-40, 2.5 mM EGTA, and 20 mM 
b-glycerolphosphate) and two times with HEPES-buffered saline 
(HBS; 10 mM HEPES-KOH, pH 7.5, and 150 mM NaCl). Finally, 
samples were boiled in protein sample buffer and subjected to 
SDS–PAGE.
Antibodies against the following targets were obtained from the 
indicated sources: Chk1 P-Ser345 and Chk1 P-Ser317 (Cell Signal-
ing Technology, Beverly, MA); Chk1 (G-4), CK1γ2 (N-20), GST (Z-5), 
and Rad17 (H-3; Santa Cruz Biotechnology, Santa Cruz, CA); Claspin 
P-Ser864 (Kumagai and Dunphy, 2003); γ-H2AX (Millipore, Billerica, 
MA); ATR (Affinity BioReagents, Golden, CO); TopBP1 (Bethyl 
Laboratories, Montgomery, TX), Rad17 P-Ser645 (a kind gift from 
Eva Y. Lee, University of California, Irvine, CA); FLAG epitope (M2, 
Stratagene, Agilent, Santa Clara, CA); and α-tubulin (Calbiochem, 
San Diego, CA).
plates and grown overnight. On the following day, a mixture of plas-
mid DNA (0.6 μg) and FuGENE 6 reagent (5 μl) was diluted in 100 μl 
H2O and incubated with cells in serum-free medium for 4 h. Next, 
medium containing FBS was added, and cells were incubated for a 
total of 48 h.
dsRNA-mediated RNA interference in S2R+ cells was performed 
essentially as described previously (Clemens et al., 2000). Briefly, 
dsRNAs (∼500 base pairs long) were produced by in vitro transcrip-
tion using DNA templates containing T7 promoters at both ends. 
The quality of dsRNAs was monitored by gel electrophoresis to en-
sure that only single bands were present. dsRNAs (15 μg) were 
added directly to 0.5 ml of serum-free medium and incubated with 
cells for 60 min. Subsequently, 1 ml complete medium with 15% 
FBS was added, and cells were incubated for another 96 h to allow 
for turnover of the proteins of interest.
Whole-cell lysates were prepared in TEB150 buffer (50 mM 
HEPES-KOH, pH 7.5, 150 mM NaCl, 2 mM MgCl2, 5 mM ethylene 
glycol tetraacetic acid [EGTA], 0.5% Triton X-100, and 10% glycerol) 
containing freshly added 1 mM dithiothreitol (DTT), 1 mM NaF, 
1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride (PMSF), and 
10 μg/ml each of pepstatin, chymostatin, and leupeptin. Lysates 
were briefly sonicated, diluted in 2× protein sample buffer, and 
resolved by SDS–PAGE.
Human cell culture and transfection
HeLa cells, U2OS cells, and U2OS T-REx cells (a kind gift from 
Thomas C. Spelsberg, Mayo Clinic, Rochester, MN) were cultured in 
DMEM containing 10% FBS, penicillin, and streptomycin. Plasmid 
DNA transfections were performed using the FuGENE 6 reagent, 
and siRNA (50 nM) transfections were carried out with Lipofectamine 
RNAiMAX (Invitrogen), according to the manufacturer’s instructions. 
For cotransfection experiments with the U2OS T-Rex cells, a 2:1 ratio 
of GST-CKAD reporter plasmid to the kinase expression plasmid was 
used. Transfections were carried out for a total of 48 h, and kinase 
expression was induced by treatment with doxycycline (100 ng/ml) 
for 16 h.
Plasmids
The pMT-Chk1-NLS-GST reporter plasmid was generated by a 
two-step cloning method. First, the NLS-GST fragment was gener-
ated by PCR and inserted into the Drosophila expression vector 
pMT/V5-His B plasmid (Invitrogen). Next, the sequence encoding 
the full-length Xenopus Chk1 was ligated in-frame to the 5′ end of 
the NLS-GST sequence. The pUAST Drosophila casein kinase ex-
pression plasmids were kind gifts from Jin Jiang (University of 
Texas Southwestern Medical School, Dallas, TX). The full-length 
cDNA clones of human CK1γ1, CK1γ2, and CK1γ3 were purchased 
from Open Biosystems (Thermo Scientific, Lafayette, CO). We also 
obtained cDNAs encoding CK1α, a short and long form of CK1δ 
(409 and 415 amino acids in length, respectively), and CK1ε from 
the same source. For expression in human cells, these cDNAs were 
cloned into the tetracycline-inducible pcDNA5/TO (Invitrogen) 
partially pairs with the FLAG-tagged version of CK1γ1 isoform C in the expression plasmid. (D and E) Knockdown of 
CK1γ1 isoform C expression only partially compromises phosphorylation of Claspin and activation of Chk1. U2OS cells, 
transfected with the different siRNAs as indicated, were treated with APH, and whole-cell lysates were then prepared 
and analyzed by immunoblotting. (F and G) Rescue experiment. U2OS cells were concurrently infected with three 
lentiviruses encoding siRNA-resistant forms of CK1γ1 isoforms A, B, and C. After siRNA transfection and treatment with 
APH as indicated, whole-cell lysates were prepared and analyzed by immunoblotting. Quantitation of the band 
intensities was performed with the Odyssey Imaging System. Relative levels of phosphorylation of Claspin and Chk1 
were calculated and plotted in (G). (H) Model for the role of CK1γ1 in mediating the activation of Chk1.
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cells were first transfected with pcDNA5-FLAG-CK1γ1 plasmids for 
48 h. Cells were then fixed and stained with anti-FLAG (M2) anti-
body and Alexa Fluor 488–conjugated anti–mouse secondary anti-
bodies.
Flow-cytometry analysis
For detection of replicating cells in S phase, cells were labeled with 
10 μM EdU for 45 min and stained with the Click-iT system. Briefly, 
cells were fixed with 70% ethanol and incubated overnight. After 
undergoing washing with PBS containing 1% bovine serum albu-
min (BSA), cells were stained with freshly prepared Click-iT reac-
tion cocktail containing Alexa Fluor 488 azide for 30 min at room 
temperature. Finally, cells were washed again, treated with RNase 
A (50 μg/ml), and counterstained with 7-amino-actinomycin D 
(7-AAD). Flow-cytometry analyses were performed with a FACS-
Calibur flow cytometer (BD Biosciences, San Jose, CA). For G2/M 
checkpoint assays, cells were treated with UV (20 J/m2) and incu-
bated for 1 h. Cells were then fixed and stained with anti–phos-
pho-histone H3 (Ser10) antibody conjugated to Alexa Fluor 488.
Cell survival assays
U2OS cells transfected with control or CK1γ1 siRNAs were seeded 
in 6-well plates at low density (∼200 cells/well). Cells were treated 
with HU (0, 0.1, 0.5, 1.0, and 2.0 mM) for 24 h. After removal of HU 
and addition of fresh medium, cells were continuously incubated for 
an additional 8 d and stained with crystal violet. Surviving colonies 
were counted by scanning plates with the Odyssey Imaging 
System.
Rescue experiments
Rescue experiments with lentiviruses were essentially performed as 
described previously (Qin et al., 2003). Briefly, lentiviruses express-
ing siRNA-resistant versions of CK1γ1 isoforms were produced by 
cotransfecting 293T cells with four lentivector plasmids (pFUW, 
pRSV-Rev, pMDLg/pRRE, and pVSV) in a 2:1:1:1 ratio using the Fu-
GENE 6 reagent. Viral supernatants were harvested 48 h later and 
filtered. To rescue the effect of CK1γ1 siRNA, U2OS cells were in-
fected with viruses in the presence of 10 μg/ml of Polybrene (Milli-
pore) for 8 h. After an additional incubation of 16 h, cells were trans-
fected with control or CK1γ1 siRNA. Two days after siRNA 
transfection, cells were treated with aphidicolin for 10 min, and 
whole-cell lysates were then immediately prepared, resolved on 
SDS–PAGE, and processed for immunoblotting.
Production of recombinant proteins
Recombinant CK1 gamma kinases with FLAG, hemagglutinin (HA), 
and His6 tags were produced in Sf9 insect cells and purified by 
following a previously described protocol (Kumagai and Dunphy, 
2000). Briefly, the full-length cDNAs of CK1 gamma kinases were 
cloned into the pFastBac-HA-HTa vector. Recombinant baculovi-
ruses were generated with the Bac-to-Bac system (Invitrogen), and 
recombinant proteins were purified using nickel agarose beads. For 
production of recombinant wild-type or kinase-dead (N169A) ver-
sions of GST-tagged CK1γ1, the appropriate cDNAs were cloned 
into the pGEX-4T-3 vector. Recombinant proteins were produced in 
Escherichia coli cells and purified using the Glutathione Sepharose 
4 Fast Flow beads (GE Healthcare, Waukesha, WI), according to the 
manufacturer’s instructions.
Reverse transcription PCR
Total RNA was isolated using the TRIzol RNA isolation reagent (Invit-
rogen). Reverse transcription PCR (RT-PCR) reactions were carried 
out using the SuperScript III One-Step RT-PCR System (Invitrogen) 
according to the manufacturer’s instructions. Specific primers were 
designed to span exon–intron boundaries of respective genes, en-
suring the results were not affected by genomic DNA contamina-
tion. The linear ranges of amplification cycle for each gene were 
predetermined by electrophoresis and quantification of the PCR 
products. The sequences of RT-PCR primers are listed in Table S2.
Immunoprecipitation and in vitro kinase assays
FLAG-tagged Drosophila casein kinases were expressed in S2R+ 
cells for 48 h. Whole-cell lysates were prepared and incubated with 
anti-FLAG antibody-conjugated Dynabeads at 4°C for 60 min. 
Beads were washed two times with buffer A and three times with 
HBS. The bead-bound kinases were incubated with the GST-CKAD 
fragment (500 ng) in kinase buffer (10 mM Tris-HCl, pH 7.5, 
10 mM MgCl2, and 1 mM DTT) containing 10 mM ATP at room 
temperature for 30 min. Finally, the reactions were stopped by ad-
dition of protein sample buffer and boiling. In the case of in vitro 
kinase assays using recombinant proteins, 250 ng of purified CK1γ1, 
CK1γ2, CK1γ3, or Xenopus Chk1-GST-His6 (Kumagai and Dunphy, 
2000) protein, instead of the immunoprecipitated kinases, were 
added to the reactions.
GST pulldown experiments
U2OS cells expressing GST-CKAD were lysed in TEB150 buffer 
as described above. Whole-cell lysates were incubated with 
Glutathione Sepharose 4 Fast Flow beads (GE Healthcare) at 4°C 
for 1 h. Beads were washed two times with buffer A and three times 
with HBS. Finally, the beads were boiled in an equal volume of 
2× protein sample buffer and subjected to SDS–PAGE.
Immunofluorescence staining
For immunofluorescence staining, cells grown on coverslips were 
fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) 
and permeabilized with 0.5% Triton X-100 in PBS. After undergoing 
blocking with 5% goat serum in PBS for 30 min, cells were incubated 
with primary antibodies at room temperature for 60 min. Following 
three washes with PBS, cells were incubated with Alexa Fluor 
594-conjugated secondary antibodies for 60 min. Finally, cells were 
washed, counterstained with 5 μg/ml Hoechst 33258, and mounted 
in VECTASHIELD mounting medium. For detection of EdU incorpo-
ration to assess DNA replication, the Click-iT system (Invitrogen) was 
used as described previously (Kumagai et al., 2010). For immuno-
fluorescence staining of the FLAG-tagged CK1γ1 isoforms, U2OS 
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